PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-233

  1. 2,143 Posts.
    lightbulb Created with Sketch. 576
    Pity Dungiven can’t say the removal of moving forward with TGA provisional approval would solve a lot for his gnashing of the teeth in this regard.

    that is what has blown out the share price.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.